Examining the effect of the Life Enhancement Treatment for Substance Use (LETS ACT) on residential substance abuse treatment retention

scientific article

Examining the effect of the Life Enhancement Treatment for Substance Use (LETS ACT) on residential substance abuse treatment retention is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ADDBEH.2011.01.016
P932PMC publication ID3070865
P698PubMed publication ID21310539
P5875ResearchGate publication ID49826099

P50authorCarlos BlancoQ56089029
P2093author name stringC W Lejuez
Derek R Hopko
Stephanie M Gorka
Laura MacPherson
Stacey B Daughters
Jessica F Magidson
P2860cites workA component analysis of cognitive-behavioral treatment for depressionQ28293596
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)Q29547223
Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale.Q34132596
Comorbid alcoholism and depression: treatment issuesQ34390028
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatientsQ34413083
Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related ConditionsQ34456676
Behavioral activation treatments of depression: a meta-analysisQ34593780
Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: the life enhancement treatment for substance use (LETS Act!).Q34756974
Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatmentQ35220257
Clinical implications of reinforcement as a determinant of substance use disordersQ35639040
Racial disparities in completion rates from publicly funded alcohol treatment: economic resources explain more than demographics and addiction severity.Q35955543
Treatment of depression in patients with opiate dependenceQ35958321
Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.Q36071603
A meta-analysis of randomized trials of behavioural treatment of depressionQ36954714
Behavioral activation is an evidence-based treatment for depressionQ37637459
A critical review of assessment strategies to measure the behavioral activation model of depression.Q37742851
Coping and communication-enhancing intervention versus supportive counseling for women diagnosed with gynecological cancersQ40188385
The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trialQ40515923
Help-seeking by substance abusers: the role of harm reduction and behavioral-economic approaches to facilitate treatment entry and retentionQ41551091
Effects of major depression on remission and relapse of substance dependenceQ43942696
Impact of alcohol detoxification on anxiety and depressive symptomsQ44138257
Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care studyQ44139859
Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related ConditionsQ44334304
Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patientsQ44448292
Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS).Q44689724
Context of relapse for substance-dependent adults with and without comorbid psychiatric disordersQ45142222
Perceptions of mental health and substance abuse program administrators and staff on service delivery to persons with co-occurring substance abuse and mental disorders.Q45998620
Rates and predictors of four-year readmission among late-middle-aged and older substance abuse patients.Q46002698
Trends in acute mental health care: comparing psychiatric and substance abuse treatment programsQ47957359
Policies and services in residential substance abuse programs: Comparisons with psychiatric programsQ50116169
Comparison of the frequency and enjoyability of pleasant events in cocaine abusers vs. non-abusers using a standardized behavioral inventory.Q50536722
U.S. spending for mental health and substance abuse treatment, 1991-2001.Q50759144
The Environmental Reward Observation Scale (EROS): development, validity, and reliability.Q50900913
The effect of depression on return to drinking: a prospective study.Q50901534
I. Synchrony and desynchrony in fear and avoidance.Q51303007
Do substance abuse patients with more psychopathology receive more treatment?Q51657208
Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study.Q51701712
What drove private health insurance spending on mental health and substance abuse care, 1992-1999?Q51951136
Behavioral economic approaches to reduce college student drinking.Q51982091
Long-term changes in current psychiatric diagnoses of treated opiate addicts.Q52077778
Circumstances, motivation, readiness, and suitability (the CMRS scales): predicting retention in therapeutic community treatment.Q52917210
Intent-to-treat analysis for longitudinal studies with drop-outs.Q53215415
Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change ConsortiumQ60144306
Is cognitive behavior therapy just a ‘nonspecific’ intervention for depression? A retrospective comparison of consecutive cohorts treated with cognitive behavior therapy or supportive counseling and pill placeboQ60620293
Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up studyQ69563617
Behavior therapy for drug abuse: a controlled treatment outcome studyQ72890063
The use of the Beck Depression Inventory to screen for depression in the general population: a preliminary analysisQ73526356
A brief behavioral activation treatment for depression. Treatment manualQ73795561
Depressive symptoms among African American women with HIV diseaseQ73966438
Depression as measured by the Beck Depression Inventory-II among injecting drug usersQ83283226
P433issue6
P921main subjectsubstance abuseQ3184856
P304page(s)615-623
P577publication date2011-01-21
P1433published inAddictive BehaviorsQ15751369
P1476titleExamining the effect of the Life Enhancement Treatment for Substance Use (LETS ACT) on residential substance abuse treatment retention
P478volume36

Reverse relations

cites work (P2860)
Q48079993A learning theory account of depression
Q38820950Activity enjoyment, not frequency, is associated with alcohol-related problems and heavy episodic drinking
Q37130498Adaptation of community health worker-delivered behavioral activation for torture survivors in Kurdistan, Iraq
Q89467165Adapting a peer recovery coach-delivered behavioral activation intervention for problematic substance use in a medically underserved community in Baltimore City
Q61799654An evaluation of the maintenance to abstinence (MTA) program in achieving abstinence in opioid users and improving mental health and quality of life
Q93207320Applying behavioral economic theory to problematic Internet use: An initial investigation
Q38919605Cognitive-behavioral therapies for depression and substance use disorders: An overview of traditional, third-wave, and transdiagnostic approaches
Q88562833Development and Preliminary Feasibility Study of a Brief Behavioral Activation Mobile Application (Behavioral Apptivation) to Be Used in Conjunction With Ongoing Therapy
Q57147011Effects of behavioural activation on substance use and depression: a systematic review
Q34549301Implementing Behavioral Activation and Life-Steps for Depression and HIV Medication Adherence in a Community Health Center
Q46154621Integrating Motivational Interviewing and Brief Behavioral Activation Therapy: Theoretical and Practical Considerations
Q33922554Integration of the brief behavioral activation treatment for depression (BATD) into a college orientation program: depression and alcohol outcomes
Q47405368Making the hard work of recovery more attractive for those with substance use disorders
Q41395800Moodivate: A self-help behavioral activation mobile app for utilization in primary care-Development and clinical considerations
Q35703179Motivation and Self-Regulation in Addiction: A Call for Convergence
Q38043440Numbing and dysphoria symptoms of posttraumatic stress disorder among Iraq and Afghanistan War veterans: a review of findings and implications for treatment
Q86372592Pilot of a Behavioral Activation-Enhanced Smoking Cessation Program for Substance Users With Elevated Depressive Symptoms in Residential Treatment
Q33921702Pilot of the brief behavioral activation treatment for depression in latinos with limited english proficiency: preliminary evaluation of efficacy and acceptability
Q46314082The effect of a behavioral activation treatment for substance use on post-treatment abstinence: a randomized controlled trial.
Q33818354The efficacy of a behavioral activation intervention among depressed US Latinos with limited English language proficiency: study protocol for a randomized controlled trial
Q37033880The efficacy of behavioral activation treatment among depressed Spanish-speaking Latinos
Q27310906The efficacy of behavioural activation treatment for co-occurring depression and substance use disorder (the activate study): a randomized controlled trial
Q40457261Theory-driven intervention for changing personality: expectancy value theory, behavioral activation, and conscientiousness.
Q54945627Therapist tips for the brief behavioural activation therapy for depression - revised (BATD-R) treatment manual practical wisdom and clinical nuance.
Q37939720Treatment failure in behavior therapy: focus on behavioral activation for depression

Search more.